Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-24-001650
Filing Date
2024-09-27
Accepted
2024-09-27 16:15:38
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-K nnvc-20240630x10k.htm   iXBRL 10-K 2357752
2 EX-10.34 nnvc-20240630xex10d34.htm EX-10.34 42513
3 EX-19.1 nnvc-20240630xex19d1.htm EX-19.1 48109
4 EX-23 nnvc-20240630xex23.htm EX-23 4238
5 EX-31.1 nnvc-20240630xex31d1.htm EX-31.1 12180
6 EX-31.2 nnvc-20240630xex31d2.htm EX-31.2 12479
7 EX-32.1 nnvc-20240630xex32d1.htm EX-32.1 6257
8 EX-32.2 nnvc-20240630xex32d2.htm EX-32.2 6362
  Complete submission text file 0001410578-24-001650.txt   7816258

Data Files

Seq Description Document Type Size
9 EX-101.SCH nnvc-20240630.xsd EX-101.SCH 53582
10 EX-101.CAL nnvc-20240630_cal.xml EX-101.CAL 38304
11 EX-101.DEF nnvc-20240630_def.xml EX-101.DEF 260001
12 EX-101.LAB nnvc-20240630_lab.xml EX-101.LAB 427768
13 EX-101.PRE nnvc-20240630_pre.xml EX-101.PRE 351054
77 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20240630x10k_htm.xml XML 930879
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36081 | Film No.: 241335066
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)